NCM
SNTI icon

Nantahala Capital Management’s Senti Biosciences Holdings SNTI Stock Holding History

Nantahala Capital Management’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$721K Hold
888,000
– – 0.03% 145
2025
Q4 		$924K Hold
888,000
– – 0.03% 137
2025
Q3 		$1.25M Hold
888,000
– – 0.04% 139
2025
Q2 		$1.87M Hold
888,000
– – 0.07% 126
2025
Q1 		$2.98M Buy
+888,000
New +$3.46M 0.12% 98

Other funds holding SNTI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
MVM
Menlo Ventures Management Menlo Park, California $327M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

Nantahala Capital Management's SNTI Position: Q1 2026 in Review

Nantahala Capital Management held its Senti Biosciences Holdings (SNTI) position steady in Q1 2026 at 888,000 shares worth $721K. The position accounts for 0.03% of the portfolio, ranked #145.

Nantahala Capital Management first reported a position in SNTI in Q1 2025 and has held it in 5 quarters since. The position peaked at $2.98M in Q1 2025. 16 funds tracked by Wall St. Rank hold SNTI as of Q1 2026.

  • Nantahala Capital Management held 888,000 shares of Senti Biosciences Holdings worth $721K as of Q1 2026.
  • Nantahala Capital Management left its Senti Biosciences Holdings share count unchanged in Q1 2026.
  • Senti Biosciences Holdings made up 0.03% of Nantahala Capital Management's portfolio in Q1 2026, its #145 holding.
  • Nantahala Capital Management first reported a position in Senti Biosciences Holdings in Q1 2025 and has held it in 5 quarters since.
  • Nantahala Capital Management's Senti Biosciences Holdings position peaked at $2.98M in Q1 2025.
  • 16 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q1 2026.

Based on Nantahala Capital Management's 13F filing for Q1 2026, filed 15 May 2026.